Correlation Between Enlivex Therapeutics and Daktronics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Daktronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Daktronics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Daktronics, you can compare the effects of market volatilities on Enlivex Therapeutics and Daktronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Daktronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Daktronics.

Diversification Opportunities for Enlivex Therapeutics and Daktronics

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Enlivex and Daktronics is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Daktronics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daktronics and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Daktronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daktronics has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Daktronics go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Daktronics

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Daktronics. In addition to that, Enlivex Therapeutics is 2.26 times more volatile than Daktronics. It trades about -0.24 of its total potential returns per unit of risk. Daktronics is currently generating about 0.25 per unit of volatility. If you would invest  1,313  in Daktronics on August 28, 2024 and sell it today you would earn a total of  177.00  from holding Daktronics or generate 13.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enlivex Therapeutics  vs.  Daktronics

 Performance 
       Timeline  
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Daktronics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Daktronics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward-looking signals, Daktronics is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Enlivex Therapeutics and Daktronics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enlivex Therapeutics and Daktronics

The main advantage of trading using opposite Enlivex Therapeutics and Daktronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Daktronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daktronics will offset losses from the drop in Daktronics' long position.
The idea behind Enlivex Therapeutics and Daktronics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance